Literature DB >> 1544672

Glomerulonephritis with organized deposits: a mesangiopathic, not immune complex-mediated disease? A pathologic study of two cases in the same family.

G Mazzucco1, E Maran, C Rollino, G Monga.   

Abstract

Similar glomerular changes (marked widening of the mesangial stalk, irregular basement membrane thickening, and presence of mesangial and subendothelial deposits) were observed by light microscopy in renal biopsy specimens from two patients (mother and daughter) affected by nephrotic syndrome. Electron microscopy disclosed huge glomerular electron-dense deposits containing 12-nm fibrils in both patients. Immunohistochemical investigations performed with antisera anti-immunoglobulin (Ig) and anti-complement fractions, anti-laminin, anti-collagen IV, and anti-fibronectin (FN) showed scant and focal Ig and complement deposits and strong deposits of FN in the mesangium and along glomerular basement membranes. Most glomerular FN was plasma-derived, as shown by immunohistochemical tests with monoclonal antibodies specific for both plasma and cell-derived FN (IST-4) and for cell-derived FN (IST-9). Electron-dense deposits with fibrillar component could hardly correspond to the Ig and complement deposits, whereas they could be related to FN deposits. Since it is known that in glomeruli FN binds to Ig and immune complexes, and the latter seem to be too scant to justify light and electron microscopic lesions and clinical findings, the hypothesis of a primary mesangiopathic glomerulonephritis in some way connected with abnormal plasma FN deposition within the glomeruli and subsequent non-specific immune reactant entrapment could be considered. We could be dealing with a peculiar form of fibrillary glomerulonephritis with rather indolent evolution, as shown by a slow decrease of glomerular function and the scarcely modified glomerular changes found in the second biopsy performed in the mother 8 years after the first investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544672     DOI: 10.1016/0046-8177(92)90013-s

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Authors:  K O Alsaad; A M Herzenberg
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

2.  The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster.

Authors:  M Vollmer; M Jung; F Rüschendorf; R Ruf; T Wienker; A Reis; R Krapf; F Hildebrandt
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

3.  Mutations in FN1 cause glomerulopathy with fibronectin deposits.

Authors:  Federica Castelletti; Roberta Donadelli; Federica Banterla; Friedhelm Hildebrandt; Peter F Zipfel; Elena Bresin; Edgar Otto; Christine Skerka; Alessandra Renieri; Marta Todeschini; Jessica Caprioli; Rosa Maria Caruso; Rosangela Artuso; Giuseppe Remuzzi; Marina Noris
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

4.  Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).

Authors:  Bruce I Goldman; Bernard J Panner; Stephen L Welle; Matthew D Gross; Daniel A Gray
Journal:  CEN Case Rep       Date:  2021-04-10

5.  Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli.

Authors:  Anjali A Satoskar; John P Shapiro; Cherri N Bott; Huijuan Song; Gyongyi M Nadasdy; Sergey V Brodsky; Lee A Hebert; Daniel J Birmingham; Tibor Nadasdy; Michael A Freitas; Brad H Rovin
Journal:  Mod Pathol       Date:  2012-01-27       Impact factor: 7.842

6.  Extraglomerular Vascular Involvement of Glomerulopathy with Fibronectin Deposits.

Authors:  Masayuki Hara; Tetsuro Kusaba; Kenshi Ono; Naoko Masuzawa; Itaru Nakamura; Noriko Urata; Hirokazu Shiraishi; Shigeo Hara; Eiichi Konishi; Satoaki Matoba; Yayoi Shiotsu; Keiichi Tamagaki
Journal:  Intern Med       Date:  2021-02-08       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.